Daratumumab plus VRd significantly improves survival in newly diagnosed multiple myeloma, supporting its role as a new ...

Cancer Center's lymphoma specialist, Dr. Palomba, provides an in-depth look at how CAR T-cell therapy is evolving to offer hope for more patients battling hematologic malignancies.

The Medical University of South Carolina Health has established the Rena N. Grant Sickle Cell Center to help treat those ...

Explore how T cell engagers could transform cancer and autoimmune treatments through promising trials and key collaborations.

The addition of nab-paclitaxel to gemcitabine and cisplatin did not improve survival in advanced biliary tract cancer.

Panelists discuss how clinicians can effectively manage patients with high-risk myelofibrosis with cytopenias through careful treatment selection, dose modification strategies, and monitoring of ...

Tents have been set up at the Renk Civil Hospital, where water scarcity and diseases resulting from contaminated water are ...

Unrelated cord blood transplant demonstrated efficacy in patients with blood cancer after microcystic adnexal carcinoma.

In this video, Aruna Padmanabhan, MD, discusses the evaluation of PI3K inhibitor combinations as first-line treatment for patients with metastatic breast cancer.

Breast cancer survivors who developed incident myocardial infarction or heart failure exhibited increased risk for adverse oncologic outcomes, according to a population-based cohort study.The findings ...

A GROUNDBREAKING gene-editing treatment for sickle cell disease has been approved for use in the UK by the NHS, offering the potential for a cure. Known as exagamglogene autotemcel (exa-cel), this one ...

The Division of Hematology/Oncology provides a full range of inpatient and outpatient services for children and adolescents with malignancies and blood disorders. The Division of Pediatric ...